Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)

Cyclerion Therapeutics has reported Other Non Operating Income over the past 3 years, most recently at $30000.0 for Q3 2025.

  • Quarterly results put Other Non Operating Income at $30000.0 for Q3 2025, down 28.57% from a year ago — trailing twelve months through Sep 2025 was $117000.0 (down 58.36% YoY), and the annual figure for FY2024 was $208000.0, down 41.9%.
  • Other Non Operating Income for Q3 2025 was $30000.0 at Cyclerion Therapeutics, down from $31000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for CYCN hit a ceiling of $107000.0 in Q3 2023 and a floor of $28000.0 in Q4 2024.
  • Median Other Non Operating Income over the past 3 years was $42000.0 (2024), compared with a mean of $56111.1.
  • Biggest five-year swings in Other Non Operating Income: tumbled 72.28% in 2024 and later fell 28.57% in 2025.
  • Cyclerion Therapeutics' Other Non Operating Income stood at $101000.0 in 2023, then tumbled by 72.28% to $28000.0 in 2024, then grew by 7.14% to $30000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $30000.0 (Q3 2025), $31000.0 (Q2 2025), and $28000.0 (Q1 2025) per Business Quant data.